Insulin Dosage Calculator - Calculate Bolus & Correction Dose

An insulin dosage calculator (clinically referred to as a prandial bolus advisor) is a quantitative clinical reference framework used by patients with Type 1 diabetes mellitus, insulin-requiring Type 2 diabetes, and gestational diabetes to compute rapid-acting mealtime and correction insulin doses. Intensive basal-bolus insulin therapy mimics endogenous pancreatic beta-cell physiology by combining a steady 24-hour basal background insulin with acute prandial (mealtime) and supplemental correction boluses. When patients structure daily macronutrient targets alongside glycemic management, pairing bolus calculations with a carb calculator establishes consistent dietary carbohydrate baselines.

Physiologic flexible insulin therapy empowers individuals to match their rapid-acting insulin analog dose directly to their planned carbohydrate intake and pre-meal capillary blood glucose or continuous glucose monitor (CGM) reading. Because exogenous insulin exhibits a narrow therapeutic index, arithmetic mistakes in dividing carbohydrate grams or subtracting blood glucose targets are a leading preventable cause of severe iatrogenic hypoglycemia and rebound hyperglycemia.

According to the American Diabetes Association (ADA) Standards of Care in Diabetes, prandial insulin dosing must integrate three simultaneous clinical variables: digestible carbohydrates in the upcoming meal, pre-prandial blood glucose concentration relative to the individualized glycemic target, and active insulin remaining from prior injections. This calculator supports both U.S. units (mg/dL) and international SI units (mmol/L), separating total bolus output into its constituent Food Coverage Bolus and Hyperglycemia Correction Bolus.

Standard mealtime bolus calculation separates prandial insulin requirements into two additive mathematical components: the carbohydrate coverage dose and the glycemic correction dose. For complex meals rich in dietary fat and protein that cause delayed postprandial hyperglycemia 3 to 6 hours after eating, patients using insulin pumps often supplement standard carbohydrate counting with our Warsaw method calculator to compute Fat-Protein Units (FPUs).

Scenario A (mg/dL): An adult reads 220 mg/dL pre-dinner with a Target BG of 100 mg/dL, an ISF of 40 mg/dL/unit, a meal of 72 g carbohydrates, and an ICR of 1:12 (zero IOB):

• Food Bolus: 72 g ÷ 12 g/unit = 6.00 units
• Correction Bolus: (220 − 100) ÷ 40 = 120 ÷ 40 = 3.00 units
• Total Bolus Dose: 6.00 + 3.00 = 9.0 units of rapid-acting insulin

Scenario B (mmol/L): Pre-lunch glucose is 11.6 mmol/L against a target of 5.6 mmol/L, with an ISF of 2.0 mmol/L/unit, 45 g carbohydrates, and an ICR of 1:15: Food Bolus = 45 ÷ 15 = 3.00 U; Correction Bolus = (11.6 − 5.6) ÷ 2.0 = 3.00 U; Total Bolus = 6.0 units.

As detailed in NCBI Bookshelf Endotext clinical guidelines for insulin therapy, clinicians estimate baseline ICR and ISF from Total Daily Dose (TDD) using the Rule of 500 (ICR = 500 ÷ TDD for rapid-acting analogs) and the Rule of 1800 (ISF in mg/dL = 1800 ÷ TDD, or 100 ÷ TDD for mmol/L).

Safe execution of basal-bolus therapy requires mastery of pharmacokinetic parameters, concentration standards, and active insulin decay curves. Because resting energy expenditure influences basal insulin requirements (typically 40% to 50% of TDD), clinicians often evaluate baseline metabolism alongside a BMR calculator when assessing energy balance.

According to official FDA prescribing records on NLM DailyMed for rapid-acting insulin analogs, standard rapid-acting formulations (insulin lispro, aspart, and glulisine) exhibit an onset within 15 to 30 minutes, peak effect at 1 to 2 hours, and duration of 3 to 5 hours. Administering rapid-acting insulin 15 minutes before meals ("pre-bolusing") when glucose is in normal or elevated range aligns peak insulin activity with carbohydrate absorption, whereas pre-bolusing is withheld during hypoglycemia or gastroparesis.

Confirm that your ICR, ISF, and Target Blood Glucose have been prescribed by your endocrinologist for the current time of day. Because adiposity modulates peripheral insulin receptor sensitivity, adults tracking weight-related changes in insulin demand can cross-reference their status with our BMI calculator.

1. Select Your Blood Glucose Unit: Choose mg/dL (U.S. standard) or mmol/L (international SI standard; 1 mmol/L = 18.018 mg/dL).
2. Enter Current and Target Blood Glucose: Input your capillary fingerstick or CGM reading alongside your prescribed target glucose (commonly 100–120 mg/dL pre-meal). If blood glucose is below 70 mg/dL (3.9 mmol/L), withhold insulin and treat hypoglycemia with 15 grams of fast-acting carbohydrates (Rule of 15).
3. Input Your Insulin Sensitivity Factor (ISF): Enter how many points (in mg/dL or mmol/L) 1 unit of rapid-acting insulin lowers your blood glucose, matching your selected unit.
4. Count Digestible Carbohydrates & Enter ICR: Sum planned meal carbohydrates in grams and input your ICR denominator (enter 15 for a 1:15 ratio, or 0 carbs for an isolated correction bolus).
5. Subtract IOB & Apply Device Rounding: Subtract any active Insulin on Board (IOB) from doses within the past 3 to 4 hours, and round to 0.5-unit or 1-unit increments per your pen or syringe graduations.

Component-based bolus calculation replaces arbitrary guesswork with individualized physiological dosing, improving Time in Range (70–180 mg/dL). When patients modify physical training volume or daily caloric intake, monitoring total energy expenditure with a TDEE calculator helps anticipate shifts in carbohydrate throughput and Total Daily Dose (TDD).

• Eliminates Arithmetic Errors: Automates fractional division during symptomatic hyperglycemia or busy mealtime settings.
• Component Auditability: Separates carbohydrate coverage from correction units so patients can verify each dose driver.
• Pen & Pump Precision: Displays both 0.01-unit pump precision and 0.5-unit / 1.0-unit pen rounding equivalents.

Linear bolus formulas provide a baseline, but human glucose homeostasis is governed by dynamic physiological variables requiring clinical judgment:

• Aerobic vs. Anaerobic Exercise: Aerobic activity recruits GLUT-4 transporters independently of insulin, often requiring a 25% to 50% reduction in pre-exercise meal boluses. Intense anaerobic sprints can transiently elevate glucose via catecholamines.
• Circadian Dawn Phenomenon: Early-morning secretion of growth hormone and cortisol (04:00–08:00 AM) antagonizes insulin signaling, often necessitating a lower numerical ICR at breakfast than at lunch or dinner.
• Acute Illness & Stress Hyperglycemia: Febrile illness or corticosteroid therapy increases insulin resistance and ketogenesis, requiring sick-day blood glucose and ketone checks every 2 to 4 hours.
• Injection Site Lipohypertrophy: Repeated injections into fibrous subcutaneous mounds delay absorption. Rotate sites across the abdomen, upper outer arm, thigh, and buttock.
• Renal & Hepatic Impairment: Declining GFR (CKD Stages 3–5) prolongs systemic insulin clearance, requiring downward dose titration to prevent hypoglycemia.

Model Limitations: This educational tool does not automatically track prior injections (Insulin on Board), CGM rate-of-change trend arrows, or negative corrections below target. Always follow your physician's prescribed bolus settings.